Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (46)
  • 2024 (52)
  • 2023 (88)
  • 2022 (86)
  • 2021 (62)
  • 2020 (14)
  • 2019 (8)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (253)
  • Pharmaceuticals/Pharmacists/Physicians (227)

Drug Name

  • Oxycodone (61)
  • Opioids (59)
  • Fentanyl (44)
  • Hydromorphone (22)
  • Synthetic Opioids (13)
  • Benzodiazepines (11)
  • Morphine (11)
  • Methamphetamine (9)
  • Amphetamines (5)
  • Cocaine (5)
  • Heroin (4)
  • Methadone (4)
  • Ketamine (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • GHB (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (41)
  • New York (37)
  • New England (36)
  • St. Louis (36)
  • Seattle (25)
  • Chicago (23)
  • Houston (21)
  • Miami (21)
  • Atlanta (19)
  • Sede (16)
  • New Jersey (14)
  • San Francisco (13)
  • El Paso (12)
  • Dallas (10)
  • New Orleans (9)
  • Rocky Mountain (7)
  • Los Angeles (6)
  • Louisville (6)
  • Phoenix (6)
  • San Diego (5)
  • Omaha (3)
  • Detroit (1)
  • Philadelphia (1)
Clear All Results
368 Results - Showing 161 to 170
PRESS RELEASE

Pocatello Nurse Practitioner is Fined and Surrenders License for Unlawful Prescriptions and Fraud

BOISE – Rachel Peay-Goodman, a nurse practitioner in eastern Idaho, consented to judgment against her after admitting that she unlawfully prescribed controlled substances and submitted false claims to Medicare while working for AmeriHealth in Pocatello, announced U.S. Attorney Josh Hurwit. The judgment found Peay‑Goodman civilly liable for violating the Controlled...
PRESS RELEASE

Gloucester County Man Admits Healthcare Fraud

CAMDEN, N.J. – A Gloucester County, New Jersey, man today admitted defrauding his employer’s health insurance plan out of more than $4 million by submitting fraudulent claims for medically unnecessary compounded medications, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Cheryl Ortiz and Attorney for the...
PRESS RELEASE

Greenwood Village Psychiatrist Sentenced to Prison for Illegal Distribution of Controlled Substances and Financial Crimes

DENVER – Howard Weiss of Greenwood Village was sentenced to six months in federal prison for distributing a controlled substance outside the usual course of professional practice, for structuring financial transactions in a way to evade reporting requirements, and for engaging in monetary transactions greater than $10,000 that were derived...
PRESS RELEASE

The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances

Greenbelt, Maryland - U.S. District Judge Peter J. Messitte approved the United States’ consent decree with Abtin Youssefi-Rashti, a Montgomery County based pharmacist, and Upton Care Pharmacy, Inc. (“Upton Care”), resolving the United States’ civil allegations that Youssefi-Rashti and Upton Care violated the Controlled Substances Act (“CSA”) in illegally dispensing...
PRESS RELEASE

Long Island Doctor Sentenced to 36 Months in Prison for Illegal Distribution of Oxycodone

BROOKLYN, N.Y. - Earlier today, in federal court in Central Islip, Frank Parasmo, a former medical doctor, was sentenced by United States District Judge Joan M. Azrack to 36 months in prison for his conviction on 32 counts of unlawfully distributing oxycodone, a highly addictive prescription painkiller, to 18 patients...
PRESS RELEASE

Nurse Who Stole Painkillers, Replacing Them with Saline and Putting Surgical Patients at Risk, Sentenced to Four Years

RALEIGH, N.C. – A former Fuquay-Varina nurse was sentenced today to 48 months in prison and three years of supervised release for tampering with painkillers intended for surgery patients. On March 9, 2022, Melissa Elizabeth Chacona pled guilty to the charges. “Surgical patients trust healthcare providers to give them the...
PRESS RELEASE

Denton Physician Sentenced for Over-Prescribing Opioids

DALLAS, TX – A Denton physician has been sentenced to federal prison for drug trafficking violations announced Special Agent in Charge of the DEA Dallas Eduardo A. Chávez today. Stanley Charles Evans, 63, pleaded guilty on Sep. 12, 2022, to conspiracy to distribute and dispense controlled substances and health care...
PRESS RELEASE

Wisconsin Naturopathic Practitioner Sentenced to Twelve Months’ Imprisonment for Unlawful Prescribing of Controlled Substances

MILWAUKEE - John J. McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee, and U.S. Attorney Gregory J. Haanstad for the Eastern District of Wisconsin, announced that on May 12, 2023, Michele Nickels. was sentenced to12 months and one day of imprisonment, to be followed by two years...
PRESS RELEASE

Former Modesto Doctor Pleads Guilty to Illegally Prescribing Opioids

FRESNO, Calif. — Sawtantra Chopra, 76, of Modesto, pleaded guilty Wednesday to three counts of illegally prescribing opioids and other medication, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian M. Clark announced. According to court documents, Chopra admitted prescribing drugs — including hydrocodone, alprazolam...
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

Paginación

  • Primera página «
  • Anterior
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster